Prevention of Relapse to Opioid Addiction Using Depot Naltrexone.

Trial Profile

Prevention of Relapse to Opioid Addiction Using Depot Naltrexone.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 20 Sep 2016

At a glance

  • Drugs Naltrexone (Primary)
  • Indications Opioid abuse
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Mar 2016 Status changed from active, no longer recruiting to completed, according to results published in the New England Journal of Medicine.
    • 31 Mar 2016 Primary endpoint of the time (in weeks) to an opioid-relapse event during the 24-week treatment phase has been met, according to results published in the New England Journal of Medicine
    • 31 Mar 2016 Results published in the New England Journal of Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top